QIAGEN Malaysia

UMBI

UMBI

QIAGEN APAC

QIAGEN APEC

QIAGEN Malaysia

UMBI

Dr Chun Wei obtained his PhD at University of Malaya for his study on “Neurovirulence variation among the two genotypes of chikungunya virus in Malaysia”. He has 5 years of experience in laboratory, 6 publications, 4 poster presentations and 1 book chapter. He was awarded with 2 travel grants to attend 9^th Asian Pacific Congress of Medical Virology at Adelaide, Australia in 2012 and 16^th Biological Sciences Graduate Congress at National University of Singapore in 2011. He joined QIAGEN Biotechnology Malaysia Sdn. Bhd. since 2016 as the Application Specialist for life science and biological content research portfolios.

Dr. Nurul Syakima graduated with 1st Class Honour in Bachelor of Biomedical Science from Universiti Putra Malaysia. She obtained her Doctor of Philosophy degree in Molecular Biology from the same university, focusing on expression profiling and functional studies to understand microRNAs regulation in head and neck cancers in 2012. Currently she is a Research Fellow in UMBI, Team Leader for Cancer Genomics & Biobank Research group and also the Head of Quality Assurance. Her current research focused on understanding molecular basis of cancer and metastasis in solid tumours such as colorectal, endometrial, thyroid, breast and ovarian cancers via state-of-the-art genomics, transcriptomics and methylomics approaches. She is also the principal investigator for numerous research grants obtained both locally and internationally.

Dr. Nadiah is a research fellow from the functional genomics group in UMBI. She obtained her PhD from Universiti Putra Malaysia in 2015 focusing on drug discovery. Her current research interests is regarding extracellular vesicles and its applications as biomarkers and immune regulators in cancers. She has received several grants for researching on exosomes among which is a study to profile non coding RNAs in exosomes derived from colorectal cancer cells.

Dr. Tan is a research fellow from the Cancer Genomics & Biobank Research group UMBI. He obtained his PhD from Universiti Sains Malaysia in 2016 focusing on the roles of selected genetic variations and molecular alterations in human papillomavirus-mediated cancer of uterine cervix. His current research interests is in the field of Cancer Genetics.

Don Lee is a Life Science professional for more than 17 years and was appointed QIAGEN Market Director Life Science for Asia Pacific in Jan 2015. His work for QIAGEN, Bio-Rad Laboratories and GE Healthcare Life Sciences includes but not limited to support key Healthcare and research projects across multiple countries within Asia.

In addition, Don has more than 7 years’ experience in Life Science and Molecular diagnostic research earlier in his career contributing to development of molecular diagnostic RT-PCR detection kit in 2003 during SARS outbreak and developed immunological testing protocols for chemical warfare detection for Singapore national surveillance.

Dr Norlizan Malek is an Associate Market Development Manager for QIAGEN, responsible for QIAGEN NGS portfolio within the Asia Pacific region. She has been working at QIAGEN for 3 years, initially as an Application Lab Specialist for APEC and subsequently as a Sales Application Specialist. Prior to joining QIAGEN, she worked for a NGS service provider based in Singapore, responsible for sales and application support of NGS and other custom genomics services. Norlizan obtained her PhD from National University of Singapore, focusing on the regulation of the TGF-β signaling pathway by the nuclear receptor co-repressor in gastric cancer